Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-2-3
|
pubmed:abstractText |
During the past decade, an increasing spectrum of pathogenic Zygomycetes fungi have caused infections in humans. The preponderance of these deeply invasive infections have been caused by members of the order Mucorales. However, deeply invasive zygomycoses due to genera of the order Entomophthorales (Conidiobolus species and Basidiobolus species) have seldom been reported. We describe a granulocytopenic patient with pulmonary and pericardial zygomycosis due to Conidiobolus incongruus, describe this organism's susceptibility to antifungal agents, characterize its diagnostic microbiological characteristics, and review previously reported cases of deeply invasive zygomycosis due to Conidiobolus species. In immunocompromised patients, C. incongruus is an uncommon but highly invasive fungal pathogen that may be resistant to amphotericin B and can be distinguished from other Zygomycetes fungi by characteristic mycological features.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1058-4838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
423-30
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:7811860-Adult,
pubmed-meshheading:7811860-Amphotericin B,
pubmed-meshheading:7811860-Cardiac Tamponade,
pubmed-meshheading:7811860-Drug Resistance, Microbial,
pubmed-meshheading:7811860-Fatal Outcome,
pubmed-meshheading:7811860-Female,
pubmed-meshheading:7811860-Fungi,
pubmed-meshheading:7811860-Humans,
pubmed-meshheading:7811860-Immunocompromised Host,
pubmed-meshheading:7811860-Mucormycosis,
pubmed-meshheading:7811860-Pneumonia
|
pubmed:year |
1994
|
pubmed:articleTitle |
Invasive zygomycosis due to Conidiobolus incongruus.
|
pubmed:affiliation |
Infectious Diseases Section, National Cancer Institute, Bethesda, Maryland 20892.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|